Optimization of biologic therapies in IBD represents an important therapeutic strategy to improve clinical outcomes. Vaughn and colleagues have analysed the long-term benefits of proactive therapeutic concentration monitoring of infliximab in patients with IBD.
IBD: Infliximab dose optimization in IBD - Proactive or reactive?
Felice C.
2014
Abstract
Optimization of biologic therapies in IBD represents an important therapeutic strategy to improve clinical outcomes. Vaughn and colleagues have analysed the long-term benefits of proactive therapeutic concentration monitoring of infliximab in patients with IBD.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.